A Study of Pregabalin (Lyrica) Augmentation in Serotonin Reuptake Inhibitor-Refractory Obsessive Compulsive Disorder
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00994786 |
|
Recruitment Status
:
Recruiting
First Posted
: October 14, 2009
Last Update Posted
: April 10, 2018
|
Sponsor:
McMaster University
Collaborators:
Pfizer
Hamilton Health Sciences Corporation
Information provided by (Responsible Party):
McMaster University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | January 2019 |
| Estimated Study Completion Date : | March 2019 |